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Abstract 15 
Adipogenesis has been extensively studied using in vitro models of cellular 16 
differentiation, enabling long-term regulation of fat cell metabolism in human adipose tissue 17 
(AT) material. Many studies promote the idea that manipulation of this process could 18 
potentially reduce the prevalence of obesity and its related diseases. It is essential to understand 19 
the molecular basis of fat cell development if we are to tackle this pandemic disease, by 20 
identifying therapeutic targets and new biomarkers. This review explores murine cell models 21 
and their applications for study of the adipogenic differentiation process in vitro. We focus on 22 
the benefits and limitations of the different cell line models, with the aim of aiding data 23 
interpretation and selection of appropriate model cell lines model for future advances in adipose 24 
biology.  25 
Keywords: Adipose tissue, Adipogenesis, Cellular models, Differentiation, Anti-obesity  26 
1 Introduction 27 
Obesity is one of the most widespread problematic health conditions, having tripled 28 
worldwide since 1980 (Chooi, Ding and Magkos, 2019). The condition is caused by 29 
accumulation of excess body fat in human body, to the extent that it is associated with several 30 
life-threatening diseases, predominantly hypertension, diabetes, heart disease, osteoarthritis 31 
and cancer (Włodarczyk and Nowicka, 2019,Lohmann, Goodwin, Chlebowski et al., 2016). 32 
The alarming prevalence and severity of obesity has drastically increased both in children and 33 
adults, and corresponding morbidity and mortality has increased markedly over the past two 34 
decades (Abarca-Gómez, Abdeen, Hamid et al., 2017,Wolfenden, Ezzati, Larijani et al., 2019). 35 
According to NCD Risk Factor Collaboration, a network of health scientists around the world, 36 
suggested global occurrence of obesity could possibly reach 21% in women and 18% in men 37 
by 2025, if the trend continues (Collaboration, 2016). Therefore, understanding obesity and its 38 
intervention must become public health priorities worldwide.  39 
This complex multifactorial disease is generally caused by a decrease in energy 40 
expenditure and/or increased energy intake for a prolonged period of time, resulting in an 41 
energy imbalance (Ross, Flynn and Pate, 2016). Environmental factors, like high caloric food 42 
consumption and sedentary lifestyle are strongly associated with the dysfunctionality of 43 
adipose tissue (AT) formation, which undergoes molecular and cellular alterations affecting 44 
metabolism, insulin sensitivity and promoting local and systemic inflammation (de Ferranti 45 
and Mozaffarian, 2008,van Meijel, Blaak and Goossens, 2019). AT increases through 46 
differentiation of pre-adipocytes to greater numbers of adipocytes, referred to as hyperplasia 47 
and/or by increase of size of existing adipocytes to accommodate further lipids, known as 48 
hypertrophy (Jo, Gavrilova, Pack et al., 2009). 49 
AT is a complex organ, able to regulate whole-body energy supply through the 50 
accumulation of triglycerides. Besides adipocytes, these tissues also contain several other cell 51 
types, including fibroblasts, blood cells, endothelial cells, macrophages, and other immune 52 
cells. All these cells continuously interact to tune metabolic response and tissue expansion. 53 
Alongside its passive function, AT also plays an intricate role in whole-body homeostasis as 54 
an endocrine organ. AT produces adipokines and numerous other bioactive factors that 55 
communicate with other organs and moderate a variety of metabolic pathways (Booth, 56 
Magnuson, Fouts et al., 2016,PNandhini, Desai and Sahoo, 2019). 57 
White, brown, and beige are names given to the three types of fat cells in AT. These 58 
cells have distinct locations and functions in the human body, differing in abundance of 59 
mitochondria and in thermogenic genes expression (Giralt and Villarroya, 2013). The majority 60 
of fats in adult humans are stored in white adipocytes of white adipose tissue (WAT) featuring 61 
a single large lipid droplet which serves as a storage depot for excess energy (Han, Zaretsky, 62 
Andrade-Oliveira et al., 2017). In contrast, brown adipose tissue (BAT) cells contain multiple 63 
lipid droplets and function by generating heat through mitochondrial uncoupling of lipid 64 
oxidation that burns energy through thermogenesis (Villarroya, Cereijo, Villarroya et al., 65 
2017). As for the third type of fat, beige adipocytes were recently discovered and showed 66 
similar functions to both white and brown adipocytes. Like BAT, beige adipocytes have 67 
enhanced thermogenic capacity, high uncoupling protein-1 (UCP1) expression, and energy 68 
expenditure when activated (Mottillo, Desjardins, Crane et al., 2016). Nevertheless, all these 69 
types of fat cells work together to maintain whole-body energy homeostasis. 70 
All fat tissues are refined by a cell differentiation process, wherein preadipocytes 71 
differentiate into mature adipocytes and become fully functional. This is a complex process 72 
known as adipogenesis, that comprises of numerous stages extensively regulated by the specific 73 
expression of proteins and transcription factors leading to adipocyte development. Among 74 
them, Peroxisome proliferator-activated receptor-γ (PPARγ) and CCAAT/enhancer-binding 75 
protein-α (C/EBPα) are considered the main regulators of adipogenesis (Rosen, Walkey, 76 
Puigserver et al., 2000). They induce expression of each other mutually and have their 77 
cooperation in activating a few other adipocyte genes has been previously reported (Munawar, 78 
Prakash and Vangalapati, 2018). However, newer studies on adipogenesis have revealed that 79 
several other transcription factors including C/EBPβ, C/EBPδ, as well as some of the Krupel-80 
like factors (KLF), induce expression of PPARγ (Hammarstedt, Gogg, Hedjazifar et al., 2018). 81 
Nevertheless, transcriptional repressors including GATA2, KLF2, and CHOP have shown to 82 
reduce PPARγ expression in adipogenesis. To store or utilize energy, mature adipocytes 83 
respond to different metabolic stimuli. The various cell types are able to communicate with 84 
each other via adipokines, cytokines or lipid/glucose fluxes. Over time, adipocytes eventually 85 
lose their differentiation or thermogenic capability due to senescence (González-Casanova, 86 
Pertuz-Cruz, Caicedo-Ortega et al., 2020). 87 
Our understanding of preadipocyte differentiation using in vitro culture models has 88 
advanced significantly in recent years (Ruiz-Ojeda, Rupérez, Gomez-Llorente et al., 2016). 89 
These cellular systems have become invaluable tools to determine the mechanisms involved in 90 
adipocyte proliferation, differentiation, adipokine secretion and gene/protein expression. An in 91 
vitro model which accurately recapitulates the properties of native human AT would greatly 92 
benefit therapy development and pathology studies. Genes, proteins, and signaling pathways 93 
involved in regulation of adipocytes are now rapidly identified using modern technologies like 94 
protein arrays, microarrays, and genetic manipulation. Yet, these techniques are only valuable 95 
if the most effective cell model is used in the research efforts. Moreover, the cell lines serve as 96 
useful systems to explore biochemical characteristic and functions of key adipogenic factors 97 
and pathways. Additionally, murine derived cell culture systems have also assisted with several 98 
adipogenesis studies as they are easy to cultivate and translate to in vivo, which has further 99 
enhanced our knowledge on adipose biology (Wang, Scherer and Gupta, 2014). 100 
The aim of this review is to provide a better knowledge and understanding of murine in 101 
vitro cellular models for the study of adipogenesis, focusing mainly on the cell differentiation 102 
and their applications for anti-adipogenic effects. This article discusses information relevant to 103 
the culture systems, highlighting benefits and limitations of the cell lines as well as their 104 
applications in adipocyte biology, and provides guidance for those seeking to select an 105 
appropriate model for their work. Our goal is to support a better understanding of the science 106 
of adipocytes and AT, as well as their mechanisms will assist with the development of novel 107 
therapeutic approaches and agents that can effectively treat these conditions. 108 
2 Cellular models for study of adipogenesis 109 
The availability of a vast range of cell models has enabled extensive study on 110 
differentiation of adipocyte using cell culture systems. These models represent the stages of 111 
adipocyte development, detailing the molecular and cellular events in transition from 112 
fibroblast-like preadipocytes into adipocyte cells (Ruiz-Ojeda et al., 2016). Hence, biologists 113 
and biochemists have been able to explore new and existing mechanisms using different 114 
sources of adipose cell models which have immensely facilitated research into the 115 
differentiation process and identification of regulatory elements that assist with coordinated 116 
expression during differentiation of adipocyte genes. 117 
Unipotent preadipocyte and pluripotent cell lines are the two primary classes of in vitro 118 
cell models present for the study of adipogenesis (Figure 1) (Moreno-Navarrete and Fernández-119 
Real, 2017). Preadipocyte models are unipotent cells which are useful in understanding the 120 
molecular events responsible for preadipocyte conversion, whereas, multipotent fibroblasts 121 
cells are pluripotent models committed to different lineages and used to study the cellular 122 
determination of the separate cell fates, including adipocytes.  123 
Figure 1: Murine cell line - Schematic diagram showing the source of each unipotent and 124 
pluripotent cell line from the in vitro model to study cellular differentiation for 125 
adipogenesis 126 
Preadipocyte clonal cell lines (3T3-L1; 3T3-F442A; TA1; AP-18; Ob1771) (refer to 127 
Figure 1) present a homogenous cellular population with the same differentiation stages. The 128 
ability of these preadipocyte cells to passage indefinitely present them the lines as effective 129 
resources for study. Alternatively, pluripotent cell models can differentiate into various cell 130 
types other than adipocytes. These cell lines include C3H10T1/2, OP9 cells, mouse embryonic 131 
stem cells (mESCs) and mouse embryonic fibroblasts (MEFs) (see Figure 1). In particular, 132 
C3H10T1/2 have been beneficial for acknowledging the events responsible for lineage 133 
determination. These cell lines have various practical features that make them suitable for 134 
adipocyte studies, especially OP9 cells which hold the capacity to rapidly differentiate. 135 
Likewise, mESCs provide an effectively infinite supply of cells when combined with retinoic 136 
acid (RA) and pro-adipogenic agents. More interestingly, MEFs are established and maintained 137 
easily, they proliferate rapidly, and can yield various cell types within several days, from just 138 
a single embryo (Yusuf, Gopurappilly, Dadheech et al., 2013). It should be noted that the 139 
development stage of each cell line has minute variations in their requirements for 140 
differentiation (Kassotis, Masse, Kim et al., 2017). Nonetheless, they also have similar 141 
functionalities to mesenchymal stem cells (MSCs) and maintain stable morphology for a long 142 
period in culture. Table 1 provides a summary of murine in vitro cell models and their 143 
applications for understanding adipogenesis. 144 
Several researchers have thoroughly examined the adipogenic or anti-adipogenic 145 
potential of many pharmacological compounds including hormones and growth factors due to 146 
the availability of murine in vitro cell models. Identifying specific development markers allows 147 
us to align the development programs of each cell line. Comprehensive knowledge of the 148 
differentiation process could assist with manipulating adipocyte cell numbers to control 149 
specific diseases - study of adipocyte differentiation, expansion and endocrine function at a 150 
complex level will support the development of therapies against obesity and its metabolic 151 
complications.  152 
Table 1: Adipogenic applications of murine in vitro cell line model 153 
Cell line Adipogenic agents Differentiation time 
Reported applications  References 
3T3-L1 Dexamethasone (DEX), 3-
isobutyl-1-methylxanthine 
(IBMX) and Insulin  
7-10 days • Understanding role of 
adipocyte-related 
proteins and genes 
• Used in co-culture and 
three-dimensional culture 




adipogenic agents in 
food products and anti-
adipogenic crude extracts 
(Kim, Lee, Kim et al., 
2020,Zhao, Hu, Wang et 
al., 2019)  
3T3-F442A Insulin, Fetal bovine 
serum (FBS), Tri-
iodothyronine (T3), IBMX 
and DEX 
10-12 days • Examination of 










Bauters et al., 
2019,Khalilpourfarshbafi, 
Murugan, Sattar et al., 
2019)  
TA1 DEX, Insulin and 
Indomethacin 
6-10 days • Understanding role and 
function of adipocyte-
related proteins  
• Screening effective 
agents in adipose 
differentiation process 
• Estimating pre-existing 
and new genes involved 
in adipogenesis  
• Used in identification of 
early adipogenic markers 
(Shinohara, Murata and 
Shimizu, 
1992,Ninomiya-Tsuji, 
Torti and Ringold, 1993)  
AP-18 Combination of DEX and 
IBMX or Insulin  
7-21 days • Potential in identification 




Yoshida et al., 2010) 
Ob1771 Insulin and T3 6-8 days • Examination of different 
molecules in 
differentiation process of 
adipogenesis  
• Screening effective fatty 
acids in adipogenesis 
biology and agents 
involved in obesity and 
its related conditions  
(Abderrahim-Ferkoune, 
Bezy, Astri-Roques et al., 
2004) 
C3H10T1/2 IBMX, DEX, Insulin, and 
Troglitazone/Rosiglitazone 
12 days • Screening natural 
compounds and crude 
extract for anti-
adipogenic effects 
• Examination of the role 
and function of 
adipocyte-related 
proteins in adipogenesis  
• Estimation of the 
regulatory effects of 
non-coding RNA in 
adipogenic 
differentiation 
(Schwind, Schetting and 
Montenarh, 
2017,Hussain, Rehman, 
Luckett et al., 2020) 
OP9 Serum replacement 
method (SRM), Insulin 
oleate method (IOM) and 
Adipogenic cocktail 
method (ACM) 
2-3 days • Identification of key 
regulators in adipocyte 
related disease 
conditions 
• Screening compounds 
on early and late 
differentiation of 
adipogenesis 
• Examination of natural 
crude extracts for anti-
adipogenic effects 
• Used in high-throughput 
RNA screening and 
techniques 
(Wolins, Quaynor, 





Retinoic acid (RA), 
Insulin, T3 and 
Rosiglitazone  
21 days • Characterisation of pre-
existing genes and new 
adipogenic regulatory 
genes 
• Used in advanced and 
high-throughput 
techniques 
• Identification of genetic 
and epigenetic 
mechanisms involved in 
adipogenesis 
• Potential in exploring 
developmental fate of 
(Rosen and MacDougald, 
2006,Ota, Tong, Goto et 
al., 2017) 
adipocytes origin and 







Insulin, DEX, IBMX, 
Troglitazone and FBS  
 
14 days • MEFs from genetically 
modified or knockout 
mice used for study the 
effects of genes in 
adipogenesis 
• Evaluation of the effects 






(Yusuf et al., 2013,Hou, 
Chen, Wang et al., 2020)  
  154 
 155 
Figure 2 A-E: Differentiation process - Schematic diagram presents adipocytes 156 
differentiation process of unipotent murine cell line 157 
 158 
Figure 3 A-D: Differentiation process - Schematic diagram presents adipocytes 159 
differentiation process of pluripotent murine cell line 160 
2.1 3T3-L1 Cell Line 161 
In 1974, Green and Kehinde reported the discovery of the 3T3-L1 cell line (Green and 162 
Kehinde, 1974,Antony, Debroy, Manisha et al., 2019). 3T3-L1 is an established embryonic 163 
murine preadipocyte cell line with distinctive characteristics, extensively used for the study of 164 
adipocyte biology. The cell line was originally manufactured by selecting cells from the resting 165 
state of a disaggregated 17–19 days old Swiss 3T3 mouse embryo. Its significance was 166 
recognized when it was injected into mice, which formed fat pads that could not be 167 
differentiated from their normal AT (Green and Kehinde, 1979,Kuri‐Harcuch, Velez‐delValle, 168 
Vazquez‐Sandoval et al., 2019). It is known that mature 3T3-L1 cells possess the majority of 169 
the ultrastructural properties of adipocytes in culture, i.e. same as that of an animal tissue 170 
(Novikoff, Novikoff, Rosen et al., 1980,Xiu, Xinong, Tianjia et al., 2017). Furthermore, 3T3-171 
L1 culture displays spontaneous lipid accumulation when converted into its adipocyte-like 172 
phenotype. Adipogenic cocktails, also known as adipogenic agents, are defined 173 
prodifferentiative agents required for conversion of undifferentiated cells into differentiated 174 
adipocyte cells. Insulin, dexamethasone (DEX), and 3-isobutyl-1-methylxanthine (IBMX) are 175 
the most commonly used adipogenic cocktails in 3T3-L1 cell differentiation.  176 
3T3-L1 cells are first cultured in a basal medium containing high glucose concentration, 177 
generally consisting of Dulbecco's modified Eagle's medium (DMEM) supplemented with fetal 178 
bovine serum (FBS) and antibiotics. A humidified atmosphere of 37 °C containing 5% CO2 is 179 
a standard protocol essential for cell culture. The medium is changed every 2–3 days, until the 180 
cells reach confluency. Once confluence is reached, 3T3-L1 differentiation is initiated by 181 
exchanging the growth media with the adipogenic cocktail medium, also known as induction 182 
medium. After 48 hours of exposure, the induction media is substituted with the growth 183 
medium containing insulin. Thereafter, the media is removed on day 6 and un-supplemented 184 
growth media is added. Subsequently, by day 7-10, the cells start to accumulate triglycerides 185 
in the form of lipid droplets identified as fully differentiated adipocyte-like cells. These mature 186 
fat cells grow in number and size over cultivation time and also express multiple metabolic 187 
characteristics (Figure 2-A) (Kim et al., 2020,Zhao et al., 2019). 188 
Several researchers have tried to introduce numerous adipogenic agents to create more 189 
efficient methods of obtaining improved differentiation efficiency of 3T3-L1 cells (Subra, 190 
Fontana, Visentin et al., 2003,Katafuchi, Garbers and Albanesi, 2010). Thiazolidinediones 191 
(TZDs) are agonists of PPARγ that are frequently used as an additional component for 3T3-L1 192 
differentiation. A further report by Zebish et al. suggested that the use of rosiglitazone (one of 193 
the TZDs) as an additional adipogenic agent resulted in differentiation within 2 weeks which 194 
persists for up to 10 cell passages (Zebisch, Voigt, Wabitsch et al., 2012). The experimental 195 
results indicated an increase of lipid accumulation and high glucose uptake with Troglitazone 196 
and DEX (Vishwanath, Srinivasan, Patil et al., 2013). Additionally, this combination was 197 
proven to generate better quality adipocytes over a shorter period of time in comparison to the 198 
combination of IBMX and DEX. Another study by Hua et al. on 3T3-L1 cells suggested that 199 
prolonged treatment of IBMX improved differentiation efficiency (Hua, Ke, Wang et al., 200 
2016). A recent analysis of six different commonly used adipogenic cocktails and their 201 
protocols suggested that the concentration of 0.5 mM IBMX, 1 μM DEX, and 10 μg/mL insulin 202 
is most effective for 3T3-L1 cell differentiation (Zhao et al., 2019). 203 
3T3-L1 cells are widely applicable for the study of adipocyte biology. Over the last 204 
decade, the 3T3-L1 in vitro model has been widely used to study molecular 205 
and cellular processes of adipogenesis. Studies using this cell line have focused on evaluating 206 
the role, function and possible mechanisms of adipocyte-related proteins to get a better insight 207 
of adipogenesis and its regulations. For example, Matrix Gla protein (MGP) has been identified 208 
in 3T3-L1 cells for involvement in fat metabolism and as a novel serum marker in central 209 
obesity (Li, Li, He et al., 2020). Likewise, the function of LIGHT/TNFSF14 was discovered in 210 
the diversion of energy in favour of immune activation that limited the adipogenic and 211 
thermogenic programs (Kou, Liu, Liu et al., 2019). Recently, liver kinase B1 (LKBI) was 212 
identified by up-regulation of brown adipocyte expression markers including UCP1, PGC-1α 213 
and PRDM16 in 3T3-L1 cells (Xi, Xue, Wu et al., 2019). Consequently, this work has helped 214 
us determine the use of these proteins as different biomarkers of obesity and their usefulness 215 
to acknowledge the development of obesity in adipocyte tissue.  216 
This cell line has also enabled characterization of the proteins involved in obesity and its 217 
complications to identify its remedies. For example, W. Tang and Fan characterized Sirtuin 6 218 
(SIRT6) as resulting in reduced insulin resistance and increased glucose metabolism in 3T3-219 
L1 cells (Tang and Fan, 2019). Similarly, an investigation by Kobayashi et al. on WW domain 220 
containing E3 ubiquitin protein ligase 1 (WWP1) in 3T3-L1 cells and on an in vivo model 221 
revealed that it is an obesity-inducible E3 ubiquitin ligase that assists with protection against 222 
obesity-associated oxidative stress (Kobayashi, Hoshino, Abe et al., 2019). Several other 223 
proteins have also been explored in 3T3-L1 cells for their effects on the adipocyte 224 
differentiation process. For instance, Tyrphostin-AG17 was found effective in preventing 225 
adipogenesis and lipid synthesis by activating caspase-3 mechanism which induced adipocyte 226 
apoptosis (Camacho, Segoviano-Ramírez, Sánchez-Garcia et al., 2018). In addition, the 3T3-227 
L1 cell line was also used to understand the mechanisms underlying obesity and other 228 
metabolic disorders to investigate the regulators associated with adipose development. In this 229 
case, The role of pigment epithelium-derived factor (PEDF) has been established in lipid 230 
metabolism, which has been recognized for negatively regulating adipogenesis through various 231 
signaling intermediates (Huang, Hsu, Chen et al., 2018). Table 2 provides detailed information 232 
on the proteins examined for adipogenic properties in 3T3-L1 preadipocytes cells. 233 
The large number of studies which use the 3T3-L1 cell line reflect its ability to rapidly 234 
screen and assess the inhibition of adipogenesis by measurement of intracellular triglyceride 235 
contents and lipid accumulation, making the cell line a valuable model for screening natural 236 
therapeutic agents. Some negatively regulated adipogenic compounds including bisphenol-A 237 
(BPA) and  polychlorinated biphenyls 138 (PCBs) have been shown to contribute to the 238 
induction of obesity using 3T3-L1 cells (De Filippis, Li and Rosen, 2018,Kim, Kim, Oh et al., 239 
2018). Further data on compounds investigated on 3T3-L1 cells and their possible adipogenic 240 
actions have been given in Table 3.  241 
Co-culture is the growth of two different cell types together in the same environment. 242 
The study of co-culture systems assists with observing the interactions in functional structures, 243 
being somewhat closer to interactions in vivo (Marino, Bishop, de Ridder et al., 2019,Paschos, 244 
Brown, Eswaramoorthy et al., 2015,Hendriks, Riesle and van Blitterswijk, 2007). Dodson, and 245 
his coworkers (1997) discovered that co-culture systems are applicable for the study of obesity 246 
in humans. They developed a defined system from myogenic satellite cells and muscle-derived 247 
preadipocytes to examine soluble factors involved in their communication (Dodson, Vierck, 248 
Hossner et al., 1997). A recent investigation by Hao and her team, established a 3T3-L1 cell 249 
co-culture system with human prostate cancer cells to determine the inhibition ability of 250 
arctigenin as an effective agent that can co-target obesity in obese-related prostate cancer (Hao, 251 
Diaz, del Rio Verduzco et al., 2020). According to another study, a co-cultured system of 252 
differentiated 3T3-L1 and RAW264.7 cells was used to study the mechanism of macrophage-253 
adipocytes interaction in innate and adaptive immunity (Lu, Ma, Zhao et al., 2020).  254 
This 3T3-L1 co-culture system was also used to screen plant-derived components for 255 
biological activity. For example, Brassinin (BR) was recognized for inhibition of obesity-256 
induced inflammation via Nrf2-HO-1 signaling pathway (Kang, Kim, Hwang et al., 2019). The 257 
3T3-L1 cell line was also used to further evaluate the effects of saponin fraction from red 258 
ginseng on treatment of obesity through a co-culture system (Kim, Kang, Suh et al., 2018). 259 
Hence, evidence suggest that the use of 3T3-L1 cell line in a co-culture system has been proven 260 
effective for its effects on anti-obesity and obesity related inflammations.  261 
Two-dimensional (2D) cell culture techniques usually require low-cost maintenance and 262 
are easily manipulated according to their conditions for cell growth. Yet, the tissues of the in 263 
vivo micro-environment are not fully duplicated through this approach. Therefore, three-264 
dimensional (3D) cell culture systems were introduced to overcome the limitation of the 2D 265 
culture method (Marino et al., 2019). A scaffold-free method has now been used to generate 266 
3D adipose spheroids from primary, immortal human and 3T3-L1 preadipocyte cells, 267 
developed by Turner, Tang, Weiss and Janorkar (Turner, Tang, Weiss et al., 2015). This 268 
demonstrates that 3D culture of 3T3-L1 cells can effectively identify new biomarkers and 269 
effective therapeutics.  270 
Many researchers have determined that co-culture systems better mimic the in vivo tissue 271 
microenvironment of cell morphology and structural complexity in a 3D platform, as well as 272 
biological processes and functions, such as proliferation, differentiation and gene or protein 273 
expression. A recent high-throughput proteomic analysis of 3D co-cultured system of 3T3-L1 274 
cells was utilized to explore the differential protein expression between 2D and 3D co-cultured 275 
system using the iTRAQ-bases technique. This encouraged development of an insulin resistant 276 
model that produced an in vitro obesity model identical to the  conditions of in vivo, 277 
considering the mechanisms underpinning metabolic syndromes (Lee, Park, Kim et al., 2019), 278 
consequently introducing new ways by utilizing 3T3-L1 cells to tackle obesity and its related-279 
metabolic disorders. 280 
In recent years, an integrated AT on-chip nano-plasmonic biosensing platform to 281 
investigate obesity-associated inflammation was developed using 3T3-L1 cells. The system 282 
was created for drug-efficacy screening and as a prognostic tool to create personalized 283 
treatment plans for risk prevention against obesity (Zhu, He, Verano et al., 2018). These cells 284 
were also served as a model system to develop a visual difference mapping (VDM) platform, 285 
a new method used to determine the program of adipogenesis. The system analyses the 286 
conversion process of fibroblast-like cells into a rounded shape with formation of lipid droplets 287 
(Lustig, Feng, Payan et al., 2019). These advanced techniques and high-throughput screening 288 
could assist in finding effective and potent therapies to combat obesity and its related metabolic 289 
disorders. 290 
In summary, the 3T3-L1 cell line has been used extensively in the last 50 years in 291 
lipogenesis and lipolysis research due to its abundant supply of homogeneous cells through 292 
culture, making it a good model to screen compounds for their potential antilipolytic effects 293 
(Pereira-Fernandes, Vanparys, Vergauwen et al., 2014). These preadipocyte cells are also 294 
suitable models to study molecular mechanisms and transcription factors in the adipogenesis 295 
process due to their adherent properties (Poulos, Dodson and Hausman, 2010). 3T3-L1 cells 296 
are ideal for the study of long-term regulation of adipocyte functions as they provide a 297 
monolayer culture of newly differentiated fat cells (Adler-Wailes, Guiney, Wolins et al., 2010). 298 
Though some research suggests that 3T3-L1 cells have low differentiation efficiency if they 299 
are repeatedly thawed from liquid nitrogen (Zhao et al., 2019). In addition, the cells are unable 300 
to differentiate robustly into adipocytes if they become confluent and are passaged extensively 301 
(Wolins et al., 2006,Hock, 2016,Hernández-Mosqueira, Velez-delValle and Kuri-Harcuch, 302 
2015). Hence, culturing 3T3-L1 cells can become demanding and limit utility in a generation 303 
of stable cell lines. Nonetheless, extensive research demonstrates that 3T3-L1 cells are most 304 
effective, with significantly lower-costs than other mature adipocytes cell line models. 305 
Table 2: List of proteins investigated for their adipogenic effects using 3T3-L1 in vitro cell 306 
model (↑ Increased; ↓ Decreased) 307 
No. Protein Description Mechanism Comments Reference 






Involved in fat 
metabolism and novel 
serum marker 
(Li et al., 
2020) 











3.  LIGHT/TNFSF14 Tumor necrosis factor 
superfamily protein 14 
↓ UCP1  
↓ PPARγ 
↓ PRDM16 
Involves in beige fat 
biogenesis 
(Kou et al., 
2019) 












(Xi et al., 
2019) 
5.  WW domain 
containing E3 
ubiquitin protein 
ligase 1 (WWP1) 
HECT E3 ubiquitin ligases ↓ Oxidative 
stress 
Protective role in 
oxidative stress in 
WAT 
(Kobayashi 
et al., 2019) 
6.  Protein kinase D1 
(PKD1) 
G protein-coupled receptor ↓ C/EBPα  
↓ C/EBPδ 
Deletion of PKD1 
improve insulin 
sensitivity and reduced 
liver steatosis  
(Löffler, 
Mayer, 
Viera et al., 
2018) 
 
7.  Polymerase I and 
transcription release 
factor (PTRF) 
Intracellular protein ↑ Hypertrophy  
↑ Senescence 
Behave as an adipokine 





Table 3: List of compounds, structure ID and possible mechanisms investigated in 3T3-309 
L1 preadipocyte cell line (↑ Increased; ↓ Decreased) 310 
No. Agents Structure 
ID 






















2.  Acrylamide (ACR) PubChem 
CID:6579 
Present in starch-












Choi et al., 
2019) 
3.  Salt PubChem 
CID:5234 
















↑ SREBP-1c  
↑ AMPK 
activity 




Huang et al., 
2018) 
9.  Erb-B2 Receptor 
Tyrosine Kinase 4 
(ErbB4) 
Epidermal growth factor 
(EGF) receptor family 
↑ Inflammation  
↑ 
Subcutaneous 
and visceral fat  
ErbB4 deletion 






10.  Neuregulin-4 
(Nrg4) 
EGF family of proteins ↑ Angiogenesis Disruption of Nrg4 





11.  S100A4 S100 calcium-binding 
protein family 
↓ Inflammation  





Yuan et al., 
2018) 
12.  Pentraxin 3 (PTX3) Long pentraxin protein 
family  





development of obesity   
(Chang, 
Shin, Choi et 
al., 2018) 
13.  Tyrphostin-AG17 Reversible Inhibitor of 





Anti-obesity effect (Camacho et 
al., 2018) 
14.  CD38  Type II transmembrane 
glycoprotein 
↓ PPARγ 
↓ aP2  
↓ C/EBPα 







et al., 2018) 
15.  Pigment epithelium-
derived factor 
(PEDF) 
Serine protease inhibitor 
glycoprotein 
































the herb Isodon 
adenantha 






Tian et al., 
2019) 














Sun, Xu et 
al., 2019) 
























of Platycodi radix  
↓ PPARγ 
↓ C/EBPα 
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in the essential 
oils of various 
plants  
↑ PGC-1α 

















, Min et 
al., 2018) 
13.  Plumbagin PubChem 
CID:10205 
Naphthoquinone 













































































Tian et al., 
2018) 
 311 
2.2 3T3-F442A Cell Line 312 
In 1976, Green developed 3T3-F442A cells from Swiss 3T3 embryonic fibroblasts. The 313 
cells were isolated from the 3T3 clone-18 line that converted into fat cell clusters at a high 314 
frequency, and increased size as compared to the 3T3-L1 cell line (Green and Kehinde, 315 
1976,Sadie‐Van Gijsen, 2019). This demonstrates the cells’ ability to develop morphological 316 
characteristics of mature adipocytes both in vitro and in vivo considering their spherical shape, 317 
increased lipogenic activity, accumulation of triglycerides, and adipocyte-specific marker 318 
expression. The reliability of this preadipocyte model was first tested on the nude mouse by 319 
subcutaneously injecting cells that produced ectopic fat which became histologically (Green 320 
and Kehinde, 1979) and biochemically (Mandrup, Loftus, MacDougald et al., 1997) 321 
indistinguishable from the host normal AT. Thereby, suggesting that the studies of the adipose 322 
conversion and its regulation on this model is supported hugely by the cell behavior in animals. 323 
3T3-F442A cells generally require treatment of differentiating agents such as insulin and 324 
FBS to undergo adipose differentiation, which typically suggest high adipogenic activity (Kuri-325 
Harcuch and Green, 1978). Though some researchers have also used triiodothyronine (T3), 326 
IBMX and DEX agents (Hemmeryckx et al., 2019). For differentiation, the preadipocyte cells 327 
are cultivated and maintained in a high basal medium containing DMEM supplemented with 328 
FBS and antibiotics. Evidence suggests that differentiation can be prevented by maintaining 329 
the cells at their pre-confluency stage. Once the cells reach confluency, the culture medium is 330 
exchanged for 48 hours with an induction medium. Thereafter, it is substituted with DMEM 331 
medium containing only FBS, for up to a week, replacing the media every 48 hours. Over an 332 
approximate period of 2 weeks, the cells will differentiate into adipocytes, which can be 333 
confirmed by quantification of lipid containing cells and cell viability assay (Figure 2-B) 334 
(Hemmeryckx et al., 2019,Khalilpourfarshbafi, Murugan, Sattar et al., 2019). 335 
Interestingly, defined small molecules can be used to induce commitment into 336 
adipocytes, thus this cell line has become a valuable tool to understand some of the mechanisms 337 
involved in the early stages of differentiation. For example, adipose differentiation of 3T3‐338 
F442A cells occurred rapidly when in the presence of low amounts of staurosporine, a selective 339 
serine–threonine kinase inhibitor, and absence of other adipogenic factors (Ayala-Sumuano, 340 
Velez-Del Valle, Beltrán-Langarica et al., 2008). Two stages were identified in early 341 
adipogenesis. In the first stage, staurosporine administration lasts for up to 4 hours in which 342 
GSK3β is activated. The second stabilization stage continues through from 4 to 48 hours after 343 
removal of staurosporine from the culture medium. The cells then enter into the clonal 344 
expansion stage and express the adipose specific phenotype (Ayala-Sumuano, Velez-delValle, 345 
Beltrán-Langarica et al., 2011,Diaz‐Velasquez, Castro‐Muñozledo and Kuri‐Harcuch, 2008). 346 
Identifying these stages of early adipogenesis has assisted with study of the early molecular 347 
events that regulate the induction and stabilization stages of adipogenesis process in further 348 
detail, including the participating genes and the effect of different compounds on these 349 
processes.  350 
Q. Q. Tang and Lane introduced an analog of staurosporine, stauprimide, also likely to 351 
activate the GSK3β to mediate adipose differentiation action in 3T3‐ F442A (Tang and Lane, 352 
2012). A debate on the action of DEX found that it enhanced 3T3‐F442A cell differentiation 353 
when it was induced by staurosporine, but caused impairment in lipid metabolism (Ayala-354 
Sumuano, Velez-delValle, Beltrán-Langarica et al., 2013). As a result, it was concluded that 355 
DEX may have a complex dual role in the impairment of AT homeostasis because it stimulates 356 
the differentiation process of preadipocytes. However, it also alters the lipid metabolism and 357 
insulin sensitivity of differentiated fat cells (Ayala-Sumuano et al., 2013). Thus, it has been 358 
acknowledged through the 3T3-F442A model that the actions of DEX may impair lipid 359 
homeostasis, induce insulin resistance in the organism and cause obesity. These dual actions 360 
explain the effects of DEX in vivo, along with several other studies that suggest high 361 
glucocorticoid levels could cause metabolic syndrome (Masuzaki, Paterson, Shinyama et al., 362 
2001). 363 
Farnesol is another inducer that can cause differentiation in 3T3‐F442A cells. It is a 364 
mevalonate-derived  inducer of adipocyte differentiation that also plays the role of an insulin 365 
sensitizer (Torabi and Mo, 2016). This cell line also has the capacity to differentiate into 366 
osteoblasts due to action of bone morphogenetic protein (BMP) and retinoic acid (RA) that 367 
stimulates cell proliferation, represses adipogenesis, and promotes osteoblast formation 368 
(Skillington, Choy and Derynck, 2002). In support of this notion, exposure to a specific inducer 369 
can cause these cells to oblige to either adipocytes or osteoblasts. 370 
3T3-F442A cells are less commonly utilized for adipogenic study, compared to 3T3-L1 371 
cells, considering they have minimal differences between their differentiation protocols. 3T3-372 
F442A cells are used to test compounds to evaluate their potential effects on adipogenesis and 373 
their underlying mechanisms. Tocotrienols, specific components in vitamin E family, showed 374 
inhibition in differentiation of 3T3-F442A preadipocytes. The compounds reduced triglyceride 375 
contents by decreasing glucose uptake and lowering the amount of GLUT4 and HMG-CoA 376 
reductase proteins. Consequently, tocotrienols could inhibit adipocyte differentiation and 377 
enhance energy expenditure which can render this class of vitamins useful in creation of novel 378 
dietary approaches for prevention and treatment of obesity and diabetes (Torabi, Yeganehjoo, 379 
Shen et al., 2016). Alongside, the 3T3-F442A cell line and in vivo mice models were used to 380 
examine drug supplements such as OBEX or pterostilbene to evaluate their potential anti-381 
adipogenic effects. Both drugs proved effective in reduction of adiposity in mice and in 382 
downregulation of key adipogenesis transcriptional factors (Carreira, Andrade, Gonzalez-383 
Izquierdo et al., 2018,Gomez‐Zorita, Belles, Briot et al., 2017). 384 
Many studies have been conducted on 3T3-F442A preadipocytes clonal cells to examine 385 
the potential effects of peptides and their possible molecular mechanisms in adipogenesis. For 386 
example, Egg white hydrolysate (EWH) was explored for differentiation, insulin signaling and 387 
inflammatory effects, which indicated that EWH encouraged adipocyte differentiation by 388 
combining insulin mimetic and insulin sensitizing actions on 3T3-F442A cells. Treatment with 389 
EWH also resulted in increased expression of adiponectin and suppressed cytokine mediated 390 
inflammatory response in these cells (Jahandideh, Chakrabarti, Davidge et al., 2017). 391 
Importantly, 3T3-F442A cells have facilitated the study of transcriptional factors 392 
involved in the differentiation process of adipocytes. For example, cytoglobin (Cygb) is a 393 
hexacoordinated haemoglobin protein, which when overexpressed in preadipocytes cells 394 
contributes to adipogenic differentiation as validated by higher lipid droplets and increased 395 
PPARγ, CEBPα and FABP4 expressions (Doğan, Demirci, Kıratlı et al., 2017). A few other 396 
proteins like Wnt-1 inducible signaling pathway protein-1 (WISP1) and intestinal 397 
chemosensory signaling proteins when investigated found reduced adipocytes differentiation 398 
in 3T3-F442A cells and therapeutic ability in obesity related diseases (Ferrand, Béreziat, 399 
Moldes et al., 2017,Avau, Bauters, Steensels et al., 2015).  400 
3T3-F442A cells can also be used to screen the effects of crude extracts from natural 401 
sources in aim of isolating and identifying active substances such as grape powder extract 402 
(GPE), which have been clarified for their risk/benefit in obesity and insulin resistance. Results 403 
revealed that polyphenolic extract induces browning of adipogenesis through increased glucose 404 
uptake and upregulation of AMPK signaling that upregulated energy expenditure and lipolysis 405 
in 3T3-F442A cells (Torabi and DiMarco, 2016). Hence, identifying the molecular 406 
mechanisms in adipogenic differentiation pathway could assist in developing new strategies to 407 
diagnose and prevent obesity and related diseases. Table 4 provides information on the 408 
compounds and peptides that have been explored for their adipogenic effects in 3T3-F442A 409 
cells.  410 
As with 3T3-L1, the 3T3-F442A cell line has also been used in co-culture systems to 411 
examine the in vitro effects that influence the process of adipogenesis (Christiaens, Sujatha, 412 
Hellemans et al., 2010). 3D culture of mature adipocytes has been developed within a hydrogel 413 
scaffold using 3T3-L1 and 3T3-F442A cell lines with primary human white preadipocytes cells 414 
to create a robust adipose 3D model, that caused increase in adipocytes phenotypic and 415 
genotypic markers (Louis, Pannetier, Souguir et al., 2017). Although there is limited research 416 
related to co-culture and 3D culture of 3T3-F442A cells, this cell line has the capacity for 417 
exploration of adipogenesis through these advanced systems. It has further been acknowledged 418 
that these cells are also capable of accumulating higher fat than 3T3-L1 cells and develop 419 
morphological characteristics of mature white adipocytes both in in vivo and in vitro, 420 
representing 3T3-F442A cell line as a good model for the study of biology of adipogenesis. 421 
Table 4: List of compounds and proteins investigated for adipogenic effects using 3T3-422 
F442A cells (↑ Increased; ↓ Decreased) 423 
No. Compounds Description Mechanism Comments Reference 
1.  Withaferin A 
(WFA) 
A steroidal lactone 
derived from 
Withania somnifera 










2.  OBEX Oral nutritional 
supplement 
contained many 










(Carreira et al., 2018) 











glucose uptake  
(Gomez‐Zorita et al., 
2017) 
4.  d-δ-tocotrienol 
 
Present in the 
vitamin E family 
↓ GLUT4 
↓ HMG 
CoA reductase  






(Torabi et al., 2016) 
5.  Farnesol A mevalonate-
derived 
sesquiterpene  









(Torabi and Mo, 2016) 
6.  Egg white 
hydrolysate 
(EWH) 
Dietary protein ↑ Adiponectin 











(Jahandideh et al., 
2017) 
7.  Wnt1 inducible 
signaling pathway 
protein-1 (WISP1) 
Member of CCN 
protein family 
↓ PPARγ  
↓ Adiponectin 
↓ LPL 
↓ FABP4  
Novel regulator 
of adipogenesis 
(Ferrand et al., 2017) 
8.  Cytoglobin 
(Cygb) 











(Doğan et al., 2017) 
9.  Gustatory G-
protein, gustducin, 













(Avau et al., 2015) 
10.  Gelatinase A 
(MMP-2)  
Type IV collagenase 
known as matrix 
metalloproteinase-2 






Van Hul et al., 2015) 




Grape products are 












(Torabi and DiMarco, 
2016) 
  424 
2.3 TA1 Cell Line 425 
A new preadipocyte cell line was introduced in 1984 by Chapman and his colleagues. 426 
These TA1 cells were isolated and characterized as stable adipogenic cells extracted by treating 427 
a C3H 1OT1/2 mouse embryonic fibroblast with 5-azacytidine, a DNA methylation inhibitor 428 
(Chapman, Knight, Dieckmann et al., 1984). TA1 cells express the functional and 429 
morphological characteristics of mature adipocytes through the appearance of lipid droplets 430 
and adipocyte specific RNAs. 431 
The differentiation of TA1 cells from preadipocytes to adipocytes is dramatically 432 
accelarated by the adipogenic agents DEX and insulin (Chapman, Knight and Ringold, 1985). 433 
However, in 1987, an anti-inflammatory drug known as indomethacin was recognized as a 434 
potent adipogenic inducer that stimulates differentiation in a shorter period of 3 days, with 90% 435 
adipocyte capacity in comparison to DEX-treated cells (Knight, Chapman, Navre et al., 1987). 436 
TA1 cells are maintained and cultured in 37°C with humidified air of 5% CO2 with Eagle’s 437 
basal DMEM medium, FBS and antibiotics, changing the medium every 2 days until the cells 438 
reached confluency. To induce differentiation, the cells must be exposed to the adipogenic 439 
cocktail for approximately 2 days. For the remaining days, the cells must be first washed with 440 
DMEM media and then cultured in DMEM with only fetal serum. Thereafter, the cells should 441 
begin to accumulate lipid droplets and reach differentiation approximately 6-10 days after 442 
becoming confluent (Figure 2-C) (Shinohara et al., 1992,Ninomiya-Tsuji et al., 1993). 443 
There are very few studies as to the application of this cell line for adipogenesis, yet it 444 
holds great potential. Chapman and his colleagues first discovered fat-specific protein-27 (fsp-445 
27) using TA1 cells in 1984. They cloned the protein using a screening approach to identify 446 
the cDNAs related to adipocytes differentiation (Chapman et al., 1984). However, it was later 447 
characterized by Danesch and his teams that fsp-27 plays a critical role in regulating the key 448 
adipogenic transcription of C/EBPs (Danesch, Hoeck and Ringold, 1992,Williams, Chang, 449 
Danesch et al., 1992). This cell line was also used to evaluate the mechanisms of lipogenic 450 
activity using cachectin factors which showed that cachectin reversely and specifically inhibits 451 
the expression of adipose specific genes, thereby immediately inhibiting the lipogenic activity 452 
in TA1 preadipocyte cells (Torti, Dieckmann, Beutler et al., 1985). 453 
TA1 preadipocyte cells were treated with the tumor necrosis factors (TNF) to establish 454 
their molecular mechanisms of adipogenesis. TNF resulted in reduced expression of several 455 
adipose-inducible genes which inhibit and reverse the expression of adipose genes to fully 456 
differentiated cells (Torti, Torti, Larrick et al., 1989). In later studies, TA1 cells were examined 457 
for the inhibitory role of the cell signaling protein, yielding genetic and pharmacologic 458 
evidence that TNF mediates its effects by two distinct or overlapping pathways (Reid, Torti 459 
and Ringold, 1989). Further research helped facilitate proto-oncogenes such as c-fos and c-jun 460 
that are transiently induced by TNF in TA1 cells (Haliday, Ramesha and Ringold, 1991). 461 
Ninomiya and her team provoked the idea that TNF induced c-myc expression in TA1 462 
adipocyte cells. They concluded that TNF plays a central role in inhibition and reversal of 463 
adipocyte differentiation (Ninomiya-Tsuji et al., 1993). 464 
Further studies have been conducted using TA1 cells to examine the cellular effects of 465 
chemical agents in the adipose differentiation process. For example, isoproterenol and 466 
ractopamine were investigated for lipid metabolism in TA1 preadipocytes. It was found that 467 
glycerol release increased and fatty acid synthase activity decreased by these agents in a dose-468 
dependent manner (Weber, Merkel and Bergen, 1992). Finally, the functions of collagens were 469 
evaluated using the TA1 preadipocyte cells which demonstrated that the active synthesis of 470 
collagens are required in adipose conversion of preadipocytes into adipocytes (Ibrahimi, 471 
Bonino, Bardon et al., 1992).  472 
TA1 cells have been reported to express more preexisting genes particularly involved 473 
in fatty acid and triglyceride synthesis as compared to other preadipocyte cell lines. TA1 cells 474 
also display dramatic changes in gene expression and create a large number of new gene 475 
products during adipocyte differentiation (Chapman et al., 1984). Subsequently, the qualities 476 
of the TA1 cell line make it a suitable model to evaluate the effects of preexisting and new 477 
genes that are specifically included in adipogenesis program. Evidence suggests that TA1 cells 478 
show adipocyte characteristics, like expressing early adipocyte specific genes within 479 
approximately 3 days of reaching its confluency (Torti et al., 1985). Due to this, the cell line 480 
may also be used for the identification of early adipogenic markers and their underlying 481 
mechanisms in adipogenesis. Additionally, these cells respond to physiological events in in 482 
vivo (RINGOLD, CHAPMAN, KNIGHT et al., 1988). TA1 cells may therefore be a plausible 483 
in vitro model for the study of lipid metabolism regulation. Furthermore, fully differentiated 484 
cells can be used to elucidate the effects of lipolytic and lipogenic agents in adipogenesis 485 
(Weber et al., 1992).  486 
Interestingly, a recent study comparing 3T3-L1, 3T3-F442A and TA1 cells found that TA1 487 
cells expressed higher levels of leptin than that of other cells in adipocyte differentiation 488 
(Slieker, Sloop and Surface, 1998). Regardless of the limited studies in the last 20 years, 489 
numerous scientists have made insightful discoveries for the understanding of adipose biology 490 
using TA1 cells. In summary, this cell line requires further characterization to aid in the 491 
understanding of the adipogenesis process, and introduce new discoveries to tackle obesity and 492 
its related morbidities.   493 
2.4 AP-18 Cell Line  494 
AP-18 is a another preadipocyte cell line, discovered in 2005. It was developed from the 495 
normal AT of an adult female C3H/HeM mouse, specifically derived from the subcutaneous 496 
fat of the skin behind its ears (Doi, Masaki, Takahashi et al., 2005). These cells have the ability 497 
to accumulate lipids in the form of triglycerides, and they also express characteristics of 498 
preadipocyte and mature adipocyte genes.  499 
This cell line requires differentiation agents DEX, IBMX and insulin, as with 3T3-L1 500 
cells (Chen et al., 2010). The AP-18 cells are suspended in RPMI-1640 media supplemented 501 
with FBS, sodium pyruvate, L-glutamine and antibiotics at 37 ˚C and 10% CO2. After growth, 502 
cells are treated with trypsin (0.5%) and diluted to 1:4 in a culture plate. Once the cells reach 503 
confluency, the medium is changed to high glucose RPMI-1640 medium with a combination 504 
of DEX and IBMX, otherwise insulin alone. Subsequently, the cells must be refreshed every 3 505 
days with high glucose RPMI-1640 for the following 7–21 days, wherein they will begin 506 
revealing adipocyte characteristics (Figure 2-D) (Chen et al., 2010). Through this protocol, it 507 
was discovered that AP-18-cells developed lipid accumulation at a rapid rate when cells were 508 
cultured alone, or with a relatively low concentration of insulin. The result is 70 to 90% 509 
adipocyte development within 2 to 3 weeks.  510 
Notably, when characterized for mRNA profile of adipogenesis, AP-18 cells induced 511 
expression of key transcriptional factors for adipocyte differentiation, including C/EBPβ, 512 
C/EBPα, PPARγ, aP2 and Adipisin (Doi et al., 2005). A study conducted by C. Chen and her 513 
team also confirmed that AP-18 cells differentiate into mature adipocytes by a decrease in 514 
expression of preadipocyte factor 1 (Pref-1) and increase in expression of lipoprotein lipase 515 
(LPL), retinoid X receptor-α (RXRα), PPARγ, GLUT4, adiponectin, resistin and leptin which 516 
have shown similar patterns to 3T3-L1 cells (Chen et al., 2010).  517 
Through analysis of this cell line, two apparent advantages were identified from the 518 
somewhat minimal research available on AP-18 cells. They hold the ability to grow for many 519 
generations or passage in culture at a slow growth rate whilst differentiating into adipocytes 520 
without changing their morphology (Doi et al., 2005). Secondly, AP-18 cells have been 521 
recognized as a useful model for investigating the mechanism of subcutaneous adipocyte 522 
biology because they are one of the preadipocyte cell lines that are derived from a normal AT 523 
(Doi et al., 2005). Yet, genes are expressed at a slower and lower rate in comparison to 3T3-524 
L1 cell line. It is also important to note that AP-18 cells have a doubling time of 50-60 hours, 525 
in comparison to embryo-derived 3T3-L1 cells, that double in 22 hours (Doi et al., 2005). 526 
Nevertheless, Chen Chen and her team concluded that the AP-18 cells represent specific white 527 
adipocyte phenotypes under more physiological conditions than 3T3-L1 cells (Chen et al., 528 
2010). Considering that this cell line has not yet been used for any research related to adipocyte 529 
differentiation, there is a need for further characterization to assist with developing new targets 530 
for obesity treatment through creating an understanding of its prevalence.  531 
2.5 Ob1771 Cell Line 532 
Ob1771 is another established preadipocyte cell line, obtained from subcloned Ob17 533 
cells from the fat pads of a genetically obese C57BL6J mouse. This cell line exhibits a 534 
fibroblastic shaped appearance and has shown an exponential growth rate. It has also 535 
undergone 35 passages with no detectable changes and has doubling times of 12.5 and 19 hours 536 
in 10% and 1% FBS, respectively (Sadie‐Van Gijsen, 2019,Negrel, Grimaldi and Ailhaud, 537 
1978). 538 
A standard growth medium supplemented with insulin and T3 is required for adipocyte 539 
differentiation of the Ob1771 strain (Abderrahim-Ferkoune et al., 2004). Interestingly, T3 (a 540 
thyroid growth hormone necessary for regulating the expression of differentiation-dependent 541 
genes) further stimulates the transcription of insulin-like growth factor-I (IGF-I) proteins in 542 
this cell line. A combination of IGF-I protein and T3 in medium is required for terminal 543 
differentiation of Ob17 preadipocyte cells  (Kamai, Mikawa, Endo et al., 1996,Grimaldi, Djian, 544 
Negrel et al., 1982). Similar to other preadipocyte cells, Ob1771 cells are also grown and 545 
maintained in DMEM supplemented with FBS and antibiotics. After cells become confluent, 546 
they are shifted to the differentiation induction medium with insulin and T3, changing the 547 
media every other day (Abderrahim-Ferkoune et al., 2004). Within a short period of time, key 548 
adipocyte characteristics will appear, including the formation of triacylglycerol and lipid 549 
accumulation (Figure 2-E). 550 
These characteristics are closely associated with the appearance of lipolytic and lipogenic 551 
enzymes. LPL is an early marker of adipocyte conversion and its expression is dependent upon 552 
the growth arrest stage (Amri, Dani, Doglio et al., 1986). Likewise, there is also a late 553 
differential marker whose expression is initiated by the accumulation of triacylglycerol 554 
(Ibrahimi, Abumrad, Maghareie et al., 1999,Ailhaud, Amri, Bertrand et al., 1990). Hence, 555 
expression of both early and late markers in this cell line can help track the process of 556 
adipogenesis. 557 
The use of chemically defined molecules has been investigated with these cells, 558 
reflecting the line’s reliability as a faithful in vitro model to investigate factors involved in the 559 
chronological events of adipogenesis. For example, a study on the role of spermidine concluded 560 
that it effects terminal differentiation of adipose cells and has a permissive effect on growth 561 
hormones (Amri, Barbaras, Doglio et al., 1986). Similarly, arachidonic acid is an adipogenic 562 
factor that plays a major role in controlling mitosis by increasing intracellular cyclic AMP 563 
concentrations and promoting breakdown of inositol phospholipids, subsequently, causing 564 
terminal differentiation in Ob1771 cells (Gaillard, Negrel, Lagarde et al., 1989).  565 
The Ob1771 cell line assisted in elucidating the effects of small molecules on the 566 
adipogenesis phenome. For example, fatty acids were investigated using Ob1771 cells, which 567 
revealed their role as signal transducing molecules, suggesting that they are involved in adipose 568 
cell differentiation (Amri, Ailhaud and Grimaldi, 1994,Ailhaud, Amri and Grimaldi, 1995). 569 
Later in 1997, another intrinsic adipogenic inducer for the Ob1771 cells was discovered, 570 
showing that calcitriol (1α, 25-(OH)2 vitamin D3 or VD) was able to trigger the terminal 571 
differentiation of the cells when cultured in the presence of thyroid hormone-deprived medium 572 
(Dace, Martin-El Yazidi, Bonne et al., 1997).  573 
Furthermore, the application of this cell line was used to discover the relationship 574 
between obesity and its related diseases. A potential link was recognized between insulin 575 
resistance and high blood pressure when investigated using Ob1771 cells, causing increased 576 
angiotensinogen secretion in AT, especially of obese subjects (Aubert, Safonova, Negrel et al., 577 
1998). Additionally, extracellular and intracellular signaling pathways are involved in 578 
adipocyte differentiation; it was found that leukemia inhibitory factor (LIF) and its receptors 579 
are also responsible for early adipogenesis events (Aubert, Dessolin, Belmonte et al., 1999). In 580 
a recent investigation, the efficacy of pro-nucleotides (prodrugs) were tested in Ob1771 581 
preadipocyte cells. This prodrug was considered useful for blocking obesity and related 582 
conditions due to its availability and characteristics, thus providing a potential new therapeutic 583 
approach (Laux, Pande, Shoshani et al., 2004).  584 
The greatest advantage of Ob1771 is its ability to rapidly multiply its cells as compared to 585 
other established preadipocyte cell lines. In context, the cells have a doubling time of 12.5 and 586 
19 hours in 10% and 1% FBS, respectively. On the other hand, 3T3-L1 and 3T3-F442A cells 587 
from the Swiss mouse have a doubling time of 24 hours in 10% FBS and 100 hours in 1% FBS. 588 
Furthermore, some studies suggested that low serum concentrations have a slight effect on 589 
Ob1771 cells (Doglio, Dani, Grimaldi et al., 1986); in the absence of added insulin, adipose 590 
conversion can occur significantly. Unlike other established preadipocyte cell lines, including 591 
3T3-L1 and 3T3-F442A, Ob1771 cells strictly depend on the addition of insulin. Hence, it 592 
appears that this cell line is a useful system to study differentiation of adipocyte cells and their 593 
growth factor requirements involved in cell multiplication, in contrast to preadipocytes cell line 594 
from the non-genetically obese mouse.  595 
2.6 C3H10T1/2 Cell Line  596 
In 1973, Reznikoff et al. discovered C3H10T1/2 cells, a mesenchymal cell line derived 597 
from a C3H mouse embryo aged between 14 to 17 days (Reznikoff, Brankow and Heidelberger, 598 
1973). In culture, these cells show a fibroblastic-like morphology and present similar 599 
functionalities to MSCs (Reznikoff, Bertram, Brankow et al., 1973). This multipotent fibroblast 600 
cell line can present several new types of cells such as adipose, muscles, bone and cartilage 601 
tissues when treated with an inhibitor of DNA methylation (Taylor and Jones, 1979).  602 
The transformation of C3H10T1/2 cells into mature adipocytes requires adipogenic 603 
agents such as IBMX, DEX and insulin which have proven sufficient to induce differentiation 604 
within 12 days (Schwind et al., 2017). Troglitazone or rosiglitazone can also be used to cause 605 
differentiation (Hussain et al., 2020). In a culture containing DMEM media and heat-606 
inactivated FBS, L-glutamate and antibiotics, C3H10T1/2 cells are cultivated at 37°C in a 607 
humidified atmosphere of 5% CO2. Media must be replaced every 3 days until confluency is 608 
reached. The cells are then induced for adipocyte differentiation in DMEM supplemented with 609 
an adipogenic cocktail for 2-3 more days. Eventually they start revealing their adipocyte 610 
characteristics, but until then, they must be maintained in the same culture (Figure 3-A) (Haider 611 
and Larose, 2020,Moseti, Regassa, Chen et al., 2020). Additionally, BMP4, a member of the 612 
transforming growth factor type β superfamily is able to induce commitment of C3H10T1/2 613 
cells to preadipocytes which develop into cells of the adipocyte phenotype when subjected to 614 
an adipocyte differentiation protocol (Tang, Otto and Lane, 2004). 615 
Through investigation on in vitro cell models, several pharmacological studies were 616 
conducted which assisted with the development of anti-obesity drugs from natural resources 617 
that aim to induce weight loss and reduce fat accumulation. This suggests that use of 618 
C3H10T1/2 cells has mainly focused on evaluation of the anti-adipogenic effects of phytogenic 619 
compounds, and determination of their role and functions in the adipogenesis processes. For 620 
example, oxyresveratrol, a natural compound, and pyrvinium, an anthelminthic drug have 621 
showed anti-adipogenic properties in C3H10T1/2 cells (Choi et al., 2019,Wang, Dai, Luo et 622 
al., 2019). Similarly, the anti-adipogenic effects of hybrid molecules i.e. triazole and indole 623 
derivates were investigated in both in vitro C3H10T1/2 and in vivo Syrian golden hamster 624 
model (Rajan, Puri, Kumar et al., 2018). The cell line also allows measurement of negative 625 
effects, ultimately contributing to the development of obese conditions including bisphenol-A 626 
(BPA) and benzyl butyl phthalate (BBP) (De Filippis et al., 2018,Zhang and Choudhury, 2017). 627 
C3H10T1/2 cells were also used to determine the effects of proteins and their related 628 
genes in adipocyte development to create an effective strategy to combat abnormal 629 
adipogenesis and related metabolic conditions. For instance, this cell line was used to 630 
understand the mechanism underlying the protective role of taurine, a non-proteinogenic amino 631 
acid proven useful in improving obesity by mediating the browning of WAT and activating the 632 
AMPK pathway (Guo, Li, Peng et al., 2019). An earlier study on adiponectin receptor agonist, 633 
AdipoRon in these cells was found to downregulate the expression of adipogenic transcription 634 
factors and adipocyte‑specific genes by promoting the phosphorylation of AMPK (Wang, Lu 635 
and Liu, 2017).  636 
It is vital to understand the importance of regular adipocyte proteins in the process of 637 
adipogenesis in order to find remedies for obesity related disorders. Hence, neprilysin (NEP), 638 
ahnak and CD38 were investigated in C3H10T1/2 cells to explore their role and functions in 639 
adipogenesis (Wang et al., 2018,Kim, Han, Byun et al., 2017,Shin, Seong and Bae, 2016). This 640 
cell line was also used to investigate the regulatory effects of long chain non-coding RNA 641 
(lncRNA) in obesity and adipogenic differentiation. According to another investigation, novel 642 
treatments for obesity found lncRNA Plnc1 controls adipocyte differentiation by regulating 643 
PPARγ (Zhu, Zhang, Li et al., 2018). Screening crude extracts from medicinal plants is a good 644 
strategy to discover anti-obesity drugs as it can help derive potential anti-obesity compounds. 645 
Hence, C3H10T1/2 cells were used to uncover the effects of natural plant extracts, as detailed 646 
in the table provided below (Table 5). In conclusion, we believe that such discoveries will 647 
support the potential benefits of novel anti-adipogenic and anti-lipogenic agents in future 648 
clinical studies. Table 5 presents the detailed information of compounds, proteins and extracts 649 
investigated in C3H10T1/2 cells. 650 
The C3H10T1/2 cell line is beneficial as it maintains a stable morphology even after long 651 
periods in culture. Another advantage of this mouse embryo cell line is the ability to examine 652 
the molecular genetic regulation of both the developmental determination of vertebrate stem 653 
cell lineages and their subsequent differentiation. Nonetheless, it acts as a good model to 654 
understand the events responsible for 10T1/2 lineage determination, a simple genetic control 655 
that mediates the formation of myogenic, chondrogenic and adipogenic lineages. 656 
Table 5: List of compounds, proteins and extracts which is investigated in C3H10T1/2 657 
cells (↑ Increased; ↓ Decreased) 658 
No.  Compounds  Description Mechanism Comments  Reference 
1.  25-
Hydroxycholesterol 
Specific oxysterol ↓ PPARγ 
↓ C/EBPα 
↓ FABP4 











3.  Oxyresveratrol  Stilbenoid present in mulberry 






(Choi et al., 
2019) 
4.  Bisphenol-A (BPA) Lipophilic compound, used in 
the manufacture of plastic items 








contributed in obesity 
(De Filippis 
et al., 2018) 
5.  Medicarpin (Med) Natural pterocarpan involves in 
various beneficial biological 
roles 
↑ PRDM16 
↑ PGC‐1α  







et al., 2018) 
6.  Licarin A (LA) Obtained from Mexican 
medicinal plant Aristolochia 
taliscana 
↑ PGC-1α  
↑ PRDM16  
↑ UCP1 
Induced browning 




7.  Cryptotanshinone 
(CT) 
Natural compound from Salvia 
miltiorrhiza plant 
↑ UCP1 




of white adipocytes  
(Imran, 
Rahman, 
Yoon et al., 
2017) 















9.  Protocatechuic acid 
(PCA)  
A catechol-type O-diphenol 
phenolic acid (3,4-














Kim et al., 
2017) 
10.  Benzyl butyl 
phthalate (BBP) 
An endocrine disrupting 
chemical (EDC) 
↑ aP2  
↑ PPARγ 


























12.  Artepillin C (ArtC) Brazilian propolis (a resinous 
plant-based material) 
↑ PPARγ 
↑ UCP1  
↑ PRDM16 






13.  Epigallocatechin 
gallate (EGCG) 












et al., 2016) 










Chou et al., 
2015) 
15.  Taurine Non-protein amino acid  ↑ PGC-1α 
↑ UCP 
↑ AMPK  
Increased browning 
of white adipocytes 
(Guo et al., 
2019) 
16.  Long noncoding 
RNA Plnc1 
 
Type of non-codding RNA and 
regulates cell function 
 ↑ PPARγ 
 ↑C/EBPα 




(Zhu et al., 
2018) 
17.  E1A-stimulated 
genes 1 (CREG1) 
Secreted glycoprotein and 
involves control of cell growth 
and differentiation 






18.  CD38  Type II transmembrane 
glycoprotein 
↓ PPARγ 
↓ AP2  
↓ C/EBPα 










19.  AdipoRon Adiponectin receptor agonist ↓ PPARγ  
↓ C/EBPβ  
↓ C/EBPα 









20.  Enone fatty acids Synthesized dietary 












et al., 2017) 
21.  Neprilysin (NEP) Integral plasma membrane or 
zinc metallopeptidase protein 
↑ PPARγ 
↑ C/EBPα 





(Kim et al., 
2017) 
22.  Ahnak Neuroblastomas or 







(Shin et al., 
2016) 
23.  Cytochrome P450 
1B1 (CYP1B1) 
Member of the cytochrome 

















et al., 2015) 








25.  Phytanic acid (PA) Branched-chain of fatty acid 
present in dietary food 
↑ PGC-1α 








26.  Spirulina maxima 
70% ethanol extract 
(SM70EE) 
Microalga that is rich in 
essential nutrients and contains 
pigment proteins such as 













Choi et al., 
2018) 
↓ ACC 
↑ PRDM16  
↑ PGC-1α 
↑ UCP1 
27.  Mulberry extract 
(ME) and Mulberry 
wine extract (MWE) 












et al., 2015) 
28.  Peanut sprout 
extracts (PS) 
Peanut extract from Arachis 
hypogaea L. 









Kim et al., 
2019) 
  659 
2.7 OP9 Cell Line 660 
OP9 is a stromal cell line taken from the calvarial bone marrow of a newborn C57BL/6J 661 
and C3H mouse, that is genetically deficient in functional macrophage colony-stimulating 662 
factor (M-CSF) (Nakano, Kodama and Honjo, 1994). This cell line is a tractable alternative 663 
model system for the study of adipogenesis that shows rapid accumulation of triglyceride 664 
droplets within 72 hours of differentiation (Gao, Yan, Li et al., 2010,Lane, Doyle, Fortin et al., 665 
2014). The functionalities of these cells are similar to MSCs as they acquire the ability to 666 
support and facilitate the study of molecular mechanisms involved in the development and 667 
differentiation of hematopoietic cells. During co-culture with mouse embryonic stem cells (ES 668 
cells), OP9 cells are able to induce differentiation of the cells into blood cells of erythroid, 669 
myeloid, and B cell lineages.(Gao et al., 2010,Ueno, Sakita-Ishikawa, Morikawa et al., 2003). 670 
Wolins and his colleagues described three different methodologies used for 671 
differentiation of OP9 cells; serum replacement, insulin oleate, and adipogenic cocktail 672 
methods (Wolins et al., 2006). The first step of the serum replacement method (SRM) is to 673 
grow the OP9 cells to confluence and then culture them for 2 additional days in propagation 674 
medium with α-minimum essential medium eagle (α-MEM), FBS, L-glutamine, and 675 
antibiotics. Then, the cells are cultured for a further 4 days in a serum replacement medium 676 
containing α-MEM media without FBS and antibiotics. Besides the purpose of studying insulin 677 
effects, it is important to change the medium to OP9 propagation medium after day 2 of 678 
differentiation, because the media contains high concentrations of insulin which may affect cell 679 
morphology (Figure 3-B). The second method is the insulin oleate method (IOM), whereby the 680 
propagation medium of OP9 cells are replaced with the insulin oleate medium when the cells 681 
attach to the plate. They contain α-MEM, FBS, insulin, oleate to albumin (5.5:1 molar 682 
ratio), DEX, IBMX, L-glutamine, and antibiotics. As for the adipogenic cocktail method 683 
(ACM), the OP9 cells are grown to confluence and then cultured for a further 2 days in 684 
adipocyte differentiation medium including DMEM, FBS, L-glutamine and antibiotics. The 685 
cells are cultured for 2 days in differentiation medium 1: DMEM, FBS, insulin, DEX, IBMX, 686 
L-glutamine and antibiotics. Then again, the cells are cultured for an additional 2 days in 687 
differentiation medium 2: DMEM, FBS, insulin, L-glutamine and antibiotics. All three 688 
treatment methods require OP9 cells to be maintained in propagation medium until they display 689 
the adipocyte morphology and the accumulation of triglycerides and abundant intracellular 690 
lipid droplets. This cell line expresses high levels of adipocyte specific markers like PPARγ, 691 
C/EBPα, C/EBPβ and SREBP-1c. Moreover, at its pre-confluent stage, OP9 cells express 692 
detectable levels of PPARγ and C/EBPα (Wolins et al., 2006). 693 
OP9 cells are used to identify key regulators and mechanistic in adipocyte related disease 694 
conditions for the development of a potential and effective treatment. An example is thymic 695 
adiposity, a condition which is characterized by deposition of adipocyte in age-related thymic 696 
involution causing detrimental effects on the thymic microenvironments, associated with 697 
obesity (Lamas, Lopez, Carrio et al., 2016). Some of the key regulators in thymic adipogenesis 698 
were investigated in OP9 cells using a label-free quantitative approach. This proteomic analysis 699 
revealed that transforming growth factor β (TGF-β) may have a role in thymic adiposity, 700 
indicated by inhibition in OP9-DL1 and primary thymic stromal cells. As a result, it has been 701 
acknowledged that activation of TGF-β serves as a useful tool for the prevention of thymic 702 
adiposity (Tan, Wang, Wang et al., 2019). A previous study on metabolomic alterations of 703 
thymic adipogenesis was tested in OP9 adipogenic differentiation using a liquid 704 
chromatography-mass spectrometry technique. The study suggested to address the underlying 705 
mechanism in thymic adipogenesis (Tan, Wang, Wang et al., 2017).  706 
Other research on a Ca2+ permeable channel known as transient receptor potential 707 
mucolipin 1 (TRPML1) showed involvement of intracellular membrane trafficking including 708 
lysosomal degradation and lysosomal exocytosis, although its impairment was associated with 709 
several pathophysiological conditions including obesity (Dhakal and Lee, 2019). However, 710 
when the exact role of TRPML1 was investigated in OP9 cells it was recognized that it has 711 
diverse roles. Firstly, TRPML1 is crucial for the differentiation of adipocytes and secondly, it 712 
mediates the lipid metabolism by membrane trafficking, exosome formation, and exosomal 713 
release. Subsequently, results indicated that TRPML1 is a key factor for treatment of obesity-714 
related diseases (Kim, Muallem, Kim et al., 2019).  715 
This cell line has also been used to identify the underlying mechanism for alcohol-elicited 716 
dysfunction of WAT that causes visceral adipose tissue expansion resulting in hypoxia and low 717 
inflammation within the tissue, introducing a new mechanism to target in treatment of ethanol-718 
related diabetes (He, Li, Zheng et al., 2015). It is essential to improve methods that detect the 719 
events in adipocyte differentiation in order to accelerate our understanding for treatment of 720 
metabolic and other disorders involving lipid accumulation. These treatments could potentially 721 
become powerful tools for future drug screening and mechanistic studies on adipocytic 722 
differentiation. Similarly, a new method was recently developed to study lipid 723 
accumulation through refractive index. The robustness of a digital holographic 724 
microscopy (DHM) system was tested using OP9 cells. This label-free, non-perturbing method 725 
allows detection of lipid droplets in differentiating adipocytes, without the need for washing, 726 
staining, or other liquid manipulations (Campos, Rappaz, Kuttler et al., 2018).  727 
OP9 mouse stromal cells have also been used to investigate the effects of different 728 
compounds and their underlying mechanisms on early and late differentiation of adipogenesis. 729 
With regards to drug screening, this cell line has proven a suitable model to evaluate the 730 
responses of novel drug therapies (Jiang, Di Wu, Weng et al., 2017). For example, quercetin 731 
showed anti-adipogenic and anti-lipolysis effects in OP9 stromal cells, indicating that the 732 
compound has potential anti-obesity therapeutic effect by upregulating ATGL and HSL 733 
expression and downregulating FAS, LPL and aP2 expression (Seo, Kang, Kim et al., 2015). 734 
OP9 cell lines were also used to confirm repression of lipid droplets formation. To which it 735 
was revealed that together with low cytotoxicity the extract suppresses adipogenesis associated 736 
lipid accumulation during differentiation of OP9 preadipocytes (Kato, Kato, Shibata et al., 737 
2015).  738 
OP9 cells in co-culture systems were found useful in evaluation of adipocyte biology. 739 
For example, a co-culture system using mouse bone marrow and OP9 cells indicated a novel 740 
function in control of hematopoiesis by identifying IL-1 as a therapeutic target for aged and 741 
obese individuals (Kennedy and Knight, 2015). Use of the OP9 cell line aims to generate a 742 
systemic model that identifies the genes essential for adipogenesis that can also become 743 
applicable to high-throughput RNA screening. Such models can help identify novel therapeutic 744 
targets and map disease pathways involved in obesity. Subsequently, Lane and her co-workers 745 
generated a new clonal population of OP9 cells, known as OP9-K. These cells were able to 746 
differentiate rapidly and revealed adipocyte morphology like rounded cell shape, lipid 747 
accumulation, and coalescence of lipids into a large droplet. This study contributes to the 748 
development of rapid screens that can deepen our understanding of adipose biology and test 749 
obesity therapeutics (Lane et al., 2014). Similarly, OP9-DL1 is another cell derived from the 750 
OP9 cell line characterized in order to study the commitment, differentiation, and proliferation 751 
of T-lineage in vitro that ectopically expresses Notch ligand Delta-like 1 (Dll1) by mimicking 752 
the thymic microenvironment to support T cell development in vitro (Schmitt and Zúñiga-753 
Pflücker, 2002) (Holmes and Zúñiga-Pflücker, 2009). 754 
These cells are derived non-clonally, which means that the heterogeneity of cells can 755 
be assessed for undergoing adipocytic differentiation (Campos et al., 2018). In addition, OP9 756 
cells can be preserved at high density levels without loss of potential to differentiate into 757 
adipocytes, even at high passage numbers. Consequently, these features allow the cells to be 758 
maintained in culture and within a few days the OP9 adipocytes become available for 759 
experiment (Kassotis et al., 2017). OP9 cells are given any one of three adipogenic stimuli, 760 
while rapidly accumulating triglycerides, to form numerous large lipid droplets to express 761 
adipocyte marker proteins, and assume adipocyte morphology whilst expressing late adipocyte 762 
marker proteins. However, not every protocol of OP9 cells may be optimized for adipocyte 763 
differentiation and manipulation, and when maintained at low cell density, OP9 cells adopt a 764 
spindly morphology and differentiate into adipocytes poorly (Ruiz-Ojeda et al., 2016).  765 
Accordingly, OP9 cells can differentiate into adipocytes within a period of 2 days and 766 
easily express detectable levels of transcription factors after confluency has been reached 767 
(Wolins et al., 2006). To conclude, the OP9 cell line represents a new model to understand the 768 
mechanisms of differentiation and investigate the effects of drugs on the biology of adipocytes. 769 
It is also useful for fast high-throughput studies such as non-perturbing quantification of lipid 770 
droplets and digital holographic microscopy. In summary, the capacity to rapidly differentiate 771 
and present several practical features, OP9 cell line is a suitable model for adipocyte studies.  772 
2.8 Mouse embryonic stem cells (mESCs) 773 
Martin, Evans and Kaufman described an alternative model for the study of adipogenesis 774 
biology known as mouse embryonic stem cells (mESCs). These proliferating, pluripotent stem 775 
cells deliver an unlimited supply of cells which can directly differentiate into adipocytes using 776 
a combination of RA and pro-adipogenic agents (Rosen and MacDougald, 2006). The mESCs 777 
are extracted from the inner cell mass during the developing blastocyst stage of murine embryo 778 
(Evans and Kaufman, 1981,Martin, 1981). They display numerous properties, including a 779 
stable and normal diploid karyotype, with the capacity to self-renew indefinitely and have the 780 
potential to reconstitute all embryonic lineages. Furthermore, mESCs also have the ability to 781 
integrate into an embryo and contribute to all cell lineage, whilst fully participating in fetal 782 
development when transplanted back into the mouse blastocyst (Nichols and Smith, 783 
2009,Bradley, Evans, Kaufman et al., 1984). They promote proliferation and can be maintained 784 
in the presence of LIF to remain in an undifferentiated state (Stavridis and Smith, 2003). Yet, 785 
appropriate culture conditions without LIF tend to aggregate into embryoid bodies (EBs), 786 
causing differentiation in vitro into several derivatives of all ectodermal, mesodermal, and 787 
endodermal cells. Consequently, producing all the cell types in the body (Keller, 1995). 788 
Nevertheless, mESCs potentially offer a unique in vitro cell culture system to study the initial 789 
stages of mammalian development. 790 
These highly efficient and reliable adipocytes can be differentiated with RA and pro-791 
adipogenic agents like insulin, T3 and rosiglitazone (PPARγ agonist) (Rosen and MacDougald, 792 
2006). Two main phases were recognized in the adipogenesis process of mESCs. The 793 
permissive period is the first phase of adipogenesis which requires RA and begins after the 794 
formation of EBs, causing commitment of mESC cells. In the second phase, cells are treated 795 
with adipogenic agents that cause terminal differentiation of pre-adipocytes into adipocytes 796 
and lead to outgrowth with lipid droplet-containing adipose cells (Phillips, Vernochet and Dani, 797 
2003). The mESCs are cultured and maintained at 37 °C with 5% to 10% CO2 in DMEM media 798 
on gelatin-coated plates with FBS, LIF, L-glutamate, sodium pyruvate, antibiotics and β-799 
Mercaptoethanol. To induce differentiation, mESCs cells will differentiate in up to 21 days 800 
forming a large cluster colony of mature adipocytes, confirmed by staining EBs with Oil Red 801 
O stain (refer to Figure 3-C) (Ota et al., 2017,Dani, 1999). 802 
This embryonic stem cell line is an invaluable model for the characterization of genes 803 
expressed and identification of new adipogenic regulatory genes. In recent years, mESCs have 804 
been utilized in understanding of the adipogenesis mechanisms associated with obesity. Chen 805 
and his colleagues examined RNA pol III transcripts in mESCs for their functional role, 806 
through which they discovered that Maf1 assists in promoting the mesoderm induction and 807 
adipocyte differentiation. Conversely, if Maf1 expression decreases in mESCs, then 808 
preadipocytes will display impaired adipogenesis; increased expression will enhance 809 
differentiation (Chen, Lanz, Walkey et al., 2018). The capacity for adipogenesis is determined 810 
using epigenetic regulators: the role of histone H3K27 demethylase encoded by Utx gene, has 811 
been investigated during the differentiation process of mESCs. Furthermore, results indicate 812 
that Utx mediates adipogenesis by regulating c-myc in a differentiation stage-specific manner. 813 
Targeting Utx signaling pathways is potentially valuable for the treatment of obesity, diabetes, 814 
and congenital Utx-deficiency disorders (Ota, Tong, Goto et al., 2017).  815 
In 2018, advanced tools for automated cell sorting in lineage analysis were established. 816 
Label-free quantitative imaging was used to classify the cell population on intermediate states 817 
during the differentiation of mESCs into adipocytes. The methodology was developed to 818 
distinguish undifferentiated cells from cells in other stages, and to estimate the optimal number 819 
of clusters in differentiated cells (Masia, Glen, Stephens et al., 2018). Other high-throughput 820 
techniques were developed by Guerrero-Robles and his team who introduced a new biosensor 821 
technique known as electrical bioimpedance spectroscopy (EBIS) using mESCs, MEFs and 822 
3T3-L1 cells. This method helped to identify and measure the cell lineage population, cell 823 
differentiation and undifferentiation process of adipogenesis (Guerrero-Robles, Vazquez-824 
Zapien, Mata-Miranda et al., 2017).  825 
Earlier in 2011, ultrasound standing wave traps (USWT) were used to analyze the gene 826 
expression of mESCs. The technique promised safe cell manipulation techniques for a variety 827 
of applications, including tissue engineering and regenerative medicine (Bazou, Kearney, 828 
Mansergh et al., 2011). mESCs are also used in the bioengineered 3D culture system created 829 
by Unser and Mooney et al. to open up a new arena for studying the morphology of brown 830 
adipogenesis and its implications in obesity and metabolic disorders (Unser, Mooney, Corr et 831 
al., 2016). Previously, 3D culture of mESCs has been developed using electro-spun polymer 832 
scaffolds, this in vitro 3D model mimicking the in vivo environment required to effectively 833 
study adipogenesis (Kang, Xie, Powell et al., 2007). These studies promoted the idea that 834 
mESCs could be a potential method to understand the process of adipogenesis, especially when 835 
integrated with high through-put techniques. 836 
Previous studies with immortalized mouse stromal cell line or other mesenchymal 837 
precursor cells isolated from adult tissues have been used to determine mesenchymal cell fate 838 
decisions. However, these systems were not found informative with respect to the 839 
developmental origin of mesenchymal stem cells and adipocytes (Billon, Kolde, Reimand et 840 
al., 2010). Thus, a more suitable source of embryonic cells should be used to address this issue 841 
and elucidate the exact pathways and intermediates between the embryonic stem cell and the 842 
mature adipocyte. Accordingly, mESCs have the capability to enable exploration of the 843 
developmental fate of adipocytes from their gene expression (Billon et al., 2010).  844 
A major limitation of mESCs is the heterogeneity of the culture combined with the low 845 
efficiency of the adipocyte differentiation (Schaedlich, Knelangen, Navarrete Santos et al., 846 
2010). It was later discovered that the addition of ascorbic acid (AA) in adipogenic cocktail 847 
causes robust and efficient differentiation of mESCs to mature adipocytes (Cuaranta-Monroy, 848 
Simandi and Nagy, 2015). In conclusion, this pluripotent stem cell provides a remarkable in 849 
vitro model to study the genetics and epigenetic mechanisms involved in adipogenesis and 850 
could also be promising in areas including anti-obesity drug screening and tissue engineering 851 
in order to understand the obesity-related complex diseases.   852 
2.9 Mouse Embryonic Fibroblasts (MEFs)  853 
Mouse Embryonic Fibroblasts (MEFs) are an actively used model in the study of adipose 854 
cells. This primary cell line is derived from a pregnant female mouse during 13.5 to 15.5 855 
embryonic days by removing the head, limbs, tail and internal organs from the embryos. The 856 
remaining minced carcasses are then rinsed with phosphate buffer saline (PBS), and are cut 857 
into smaller pieces. These pieces are trypsinized and seeded into a culture medium for single-858 
cell suspension forming them into a largely homogeneous population of cells after a few 859 
passages (Singhal, Sassi, Lan et al., 2016,Nagy, Gertsenstein, Vintersten et al., 2006). Primary 860 
MEFs have proven useful, but their lifespan is limited. Moreover, the isolation of these 861 
fibroblast cells is time-consuming and labour intensive, especially as they take a long time to 862 
be prepared for the experiment. After repeated transmissions, the fibroblasts will reach 863 
senescence and finally die off (Amand, Hanover and Shiloach, 2016).  864 
Researchers have developed immortal MEFs with permanent growth features using two 865 
approaches. The first approach is using serial passages of MEF cells and the second approach 866 
is the transformation of the primary MEFs by overexpressing oncogenes using viral infections 867 
(Xu, 2005). These methods develop an immortalized MEF with the desired genetic 868 
manipulations, making MEF cell line maintenance time efficient, with indefinite growth. MEFs 869 
are well-known for their use as feeder layers during culture of mESCs as they provide factors 870 
that enhance proliferation and maintenance of undifferentiated states (Hogan, Costantini and 871 
Lacy, 1986). They also assist with the study of biological properties including cell cycle 872 
regulation, immortalization, transformation, senescence, apoptosis and differentiation (Yusuf 873 
et al., 2013). In addition, these fibroblast cells can differentiate into adipogenic, chondrogenic, 874 
and osteogenic lineages expressing typical differentiation markers (Dastagir, Reimers, 875 
Lazaridis et al., 2014). 876 
As with other cell lines, MEFs are also cultured and maintained in a growth medium 877 
(DMEM media and FBS) at 37 °C and 5% CO2. To induce differentiation in these cells, cells 878 
must reach confluence, after which media is changed to adipocyte induction medium. Once 879 
triglyceride concentration is quantified and lipid content is visualized, differentiation can be 880 
confirmed by Oil red O staining (refer to Figure 3-D) (Yusuf et al., 2013) (Hou et al., 2020). 881 
The advancement of genomic manipulation has assisted with the creation of genetically 882 
engineered mice and knockout mice as efficient tools for human disease research, including 883 
the discovery, refinement, and utility of many currently available therapeutic 884 
regimes. Likewise, the cells isolated from these mutant mice could become powerful tools to 885 
study the molecular and cellular mechanisms of mutated genes under well-defined culture 886 
conditions (Dobrowolski, Fischer and Naumann, 2018). Marian E Durkin, and her team 887 
established a protocol to obtain MEF cells from genetically manipulated mouse embryos. MEF 888 
cells obtained through this procedure are suitable for use in biochemical assays and further 889 
experiments of genetic manipulation (Durkin, Qian, Popescu et al., 2013). Thus, it was 890 
acknowledged that genetically modified MEF cells can be used to better understand the 891 
adipogenesis process. Recently, MEF cells were also investigated for the metabolic footprint 892 
of early adipocyte commitment. Data indicated that ceramide induced apoptosis is essential in 893 
initiating adipogenesis by providing lipophilic components that activate adipogenic 894 
transcription factor expression and facilitate lipid droplet formation. Therefore, Sirt1 may 895 
target treatment of obesity and other ceramide-associated metabolic syndromes (Hou et al., 896 
2020). In another study, MEF cells derived from Irx3-knockout mice were developed to 897 
identify the role of Irx3 in beige preadipocyte functions and differentiation. Results suggested 898 
that complete loss of Irx3 in MEF cells could lead to reduced cell cycle progression, impaired 899 
mitochondrial respiration as well as loss of cell identity and an inability to undergo adipogenic 900 
differentiation (Bjune, Dyer, Røsland et al., 2020). Consequently, MEF cells developed from 901 
genetically modified or knockout mice are approved to study the effects of different genes in 902 
adipogenesis program. 903 
Similarly, MEF cells can also assist in evaluating the effects of protein or its gene in 904 
adipogenesis in order to create new therapeutic targets to treat obesity and its associated 905 
diseases. The 14-3-3ζ scaffold protein was investigated in MEF cells which found the novel 906 
adipogenic factors that blocked the obesity-associated expansion of AT (Mugabo, Sadeghi, 907 
Fang et al., 2018). Another example is the loss of CD38 expression in MEF cells, which impairs 908 
adipogenesis and lipogenesis (Wang et al., 2018). Follistatin (Fst) is a glycoprotein which 909 
resulted in increased browning of WAT by increasing UCP1, PRDM16 and PGC-1α expression 910 
in MEF cells (Singh, Braga, Reddy et al., 2017), whilst, Pin1 is a peptidylprolyl cis/trans 911 
isomerase that was found in enhanced adipocytes differentiation in MEF cells by increased 912 
expression of PPARγ and ERK pathway (Han, Lee, Bahn et al., 2016). Meanwhile, Interferon-913 
alpha (IFNα) was found to inhibit adipocyte differentiation at early stages of adipogenesis by 914 
decreasing the expression of PPARγ and C/EBPα (Lee, Um, Rhee et al., 2016). Additionally, 915 
ADAMTS5, a metalloproteinase superfamily protein has been identified as a promotor of 916 
angiogenesis effects in MEF cells as well as in vivo (Bauters, Scroyen, Deprez-Poulain et al., 917 
2016). Table 6 presents a list of proteins and their identified mechanism in MEFs cell in term 918 
of adipogenesis.   919 
These cell lines were also integrated with high throughput techniques to identify and 920 
characterize diverse cells types and the cell differentiation process in adipogenesis. For 921 
example, EBIS was developed to identify populations of undifferentiated mESCs, MEFs and 922 
the differentiation process from preadipocytes (3T3-L1) to mature adipocytes (Guerrero-923 
Robles et al., 2017). As with primary cultures, MEFs also have certain limitations due to their 924 
origin. Hence, the cellular heterogeneity of embryonic tissue and the culture of these cells often 925 
presents difficulties. However, a few steps could ensure a greater degree of homogeneity 926 
(Garfield, 2010). 927 
Several studies revealed that fibroblast cells were identical to MSCs, and can 928 
differentiate into bone, fat and cartilage cells. In particular, MEFs are easily established and 929 
maintained, they proliferate rapidly and a can provide a large number of cells from a single 930 
embryo (Yusuf et al., 2013). Moreover, immortalized MEFs have the potential to expand 931 
through several passages. Accordingly, these properties make MEF an attractive cell culture 932 
model to further explore and create a better understanding of adipogenesis.  933 
Table 6: List of compounds, protein and their mechanism investigated in MEF cells (↑ 934 
Increased; ↓ Decreased) 935 
No. Compound Description Mechanism Comments Reference 
1.  RepSox Inhibitor of 
transforming growth 
factor-beta receptor I 
(TGF-β-RI) 
↑ UCP1 







































↑ PPARγ Contributed in 
development of 
obesity 
(Hunt, Wang, Chen 
et al., 2017) 











Soto et al., 2016) 
6.  Chrysin An active flavonoid 












1,2-diol (2e)  






(Xu, Mao, Ding et 
al., 2015) 
8.  14-3-3ζ scaffolds 
protein 







(Mugabo et al., 
2018) 





↓ AP2  
↓ C/EBPα 







(Wang et al., 2018) 






Involved in AT 
formation 
(Wouters, Deleye, 
Hannou et al., 2017) 
11.  Follistatin (Fst) An autocrine 
glycoprotein and 
express in most tissues 
↑ UCP1  






(Singh et al., 2017) 
12.  FK506-binding protein 
51 (FKBP51) 
Intracellular protein act 
as cochaperone in heat 
shock protein 90 
(Hsp90) machinery 
 Involved in 
regulation of 
adipogenesis 
(Zhang, Qiu, Wang 
et al., 2017) 
13.  EP3 receptor  Gi protein-coupled 




bodily lipid and 
glucose 
metabolism 
(Xu, Fu, Miao et al., 
2016) 










(Han et al., 2016) 

















16.  A Disintegrin And 
Metalloproteinase with 
Thrombospondin type 1 









(Bauters et al., 2016) 










Tsukamoto et al., 
2016) 
18.  BACH1 BTB and CNC 
homology 1 (BACH1) 
repressor 




Shiraki et al., 2016) 











Kamada et al., 2016) 










(Myneni, Melino and 
Kaartinen, 2015) 










(Yu, He, Wang et al., 
2015) 
22.  Gelatinase A (MMP-2) Type IV collagenase 
known as matrix 
metalloproteinase-2 






(Bauters et al., 2015) 
23.  FTO gene The fat mass and 
obesity-associated 
protein  
↑ RUNX1T1-S  
↑ FABP4  
↑ PPARγ  





McMurray et al., 
2015) 









(Park and Lee, 2015) 
25.  MEFs injection   Formed a 
single fat pad  
Used as cell-
based therapies 




Hutson et al., 2018) 
26.  Glyphosate-based 
herbicides (GF) 









Brandani et al., 
2016) 
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3 Conclusion 1046 
Cellular differentiation is commonly used for adipogenesis studies. The process is used 1047 
to transform preadipocytes into mature adipocytes via adipogenic cocktails. These cocktails 1048 
are also known as adipogenic agents and are defined prodifferentiative agents required for 1049 
conversion of undifferentiated cells into differentiated adipocyte cells (Moreno-Navarrete and 1050 
Fernández-Real, 2017). Cultivating the cells in the growth media is a fundamental step to 1051 
prepare the preadipocyte cells for induction. Of note, a humidified atmosphere of 37°C with 5-1052 
10% CO2 is essential. Once the cells reach confluency, the cells are exposed to the adipogenic 1053 
agents, which generally vary for each cell line. The three major inducers most commonly used 1054 
for differentiation include insulin, DEX and IBMX (Zhao et al., 2019). The confluent cells are 1055 
cultured in the differentiation agents, refreshing the medium periodically. Over time, the cells 1056 
reveal adipocyte-like characteristics such as formation of lipid droplets which approve their 1057 
differentiation (Moreno-Navarrete and Fernández-Real, 2017). 1058 
There are minor differences in the differentiation protocol for each cell line that has been 1059 
discussed in Table 1. For example, additional adipogenic agents are usually necessary in FBS 1060 
medium for 3T3-L1 cell conversion, however, 3T3‐L1 cells can be differentiated with 1061 
adipogenic serum without the addition of IBMX/DEX. The absence of bovine serum or growth 1062 
hormone in the culture medium can prevent the 3T3-F442A cells from undergoing adipose 1063 
differentiation, and hereby the cells can be maintained at their pre-confluency stage 1064 
(Hemmeryckx et al., 2019). It was also identified in 1987, that an anti-inflammatory drug 1065 
known as indomethacin was a potent adipogenic inducer that stimulates differentiation in a 1066 
shorter period of 3 days, with 90% adipocyte capacity in comparison to DEX-treated cells 1067 
(Knight et al., 1987). The greatest advantage of Ob1771 is its doubling time that allow its cells 1068 
to rapidly multiply. Furthermore, some studies suggested that low serum concentrations have 1069 
a slight effect on Ob1771 cells. Wherein, during the absence of added insulin, adipose 1070 
conversion can occur significantly. We have also identified that OP9 cells can be differentiated 1071 
by three different methods (Wolins et al., 2006). All three treatment methods require OP9 cells 1072 
to be maintained in propagation medium until they differentiate into adipocytes morphology 1073 
that accumulate triglycerides and abundant intracellular lipid droplets. 1074 
Applications of these cell lines are similar, as they all assist in understanding the role 1075 
of adipocyte-related proteins and genes. However, 3T3-L1 cell line is majorly used in co-1076 
culture and three-dimensional culture systems for AT. The majority of these cell lines can be 1077 
used to screen anti-adipogenic compounds, anti-adipogenic peptides, adipogenic agents in food 1078 
products and anti-adipogenesis crude extracts. TA1 cells also have the potential to identify 1079 
early adipogenic markers. OP9 and mESCs are the more frequently used cell lines in advanced 1080 
and high-throughput techniques, since the differentiation time for the cell lines are short, 1081 
averaging around 10 days. Whilst some require the medium to be refreshed at short-time 1082 
intervals, others require a change of medium. Studies indicate that Ob1771 cells are easy to 1083 
differentiate within a short period, unlike AP-18 cells, which require RPMI 1640 medium and 1084 
a rigorous differentiation process that can take up to 21 days for differentiation. 1085 
We note that, in addition to the heterogeneous mesenchymal cell populations discussed 1086 
above, another important cellular model in the study of adipose biology is adipose-derived 1087 
tissue from mouse stromal vascular fractions (SVF), comprising of adipose stromal/stem cells 1088 
(ASC) (Cawthorn, Scheller and MacDougald, 2012,Bourin, Bunnell, Casteilla et al., 2013). 1089 
ASCs provide cell renewal and repair functions, as well as maintenance of homeostasis in AT 1090 
(Zhang, Liu, Yong et al., 2015). While these cells are significantly more heterogeneous than 1091 
the examples we have focused upon, in common with MSCs, these cells can transform into 1092 
adipogenic and other lineage in vitro (Kelly, Tanaka, Baron et al., 1998,Zheng, Cao, Li et al., 1093 
2006,Kilroy, Dietrich, Wu et al., 2018), and harvesting MSCs from AT can yield better 1094 
accessibility and greater abundance of MSCs. Furthermore, ASC fractions are thought to be 1095 
primarily composed of immune cells, which enables us to make links between the immune 1096 
system and obesity-related health problems, taking into account several studies that have 1097 
established that chronic inflammation of AT is characterized by the influx of immune cells into 1098 
AT caused by obesity (Grant and Dixit, 2015). We refer readers to recent review papers (Sadie‐1099 
Van Gijsen, 2019,Jankowski, Dompe, Sibiak et al., 2020,Chu, Nguyen Thi Phuong, Tien et al., 1100 
2019) for further detail upon the differentiation, characterization, and applications of ASCs. 1101 
An extensive number of studies have described that the development of obesity and 1102 
related metabolic diseases are mainly instigated by dysregulation of AT. Thus, developing new 1103 
strategies in this regard requires critical knowledge of molecular pathways regulating adipocyte 1104 
development and metabolism. Importantly, employing cellular models has provided essential 1105 
evidence of the contribution of AT to energy homeostasis. These cell lines have become 1106 
suitable models for study of adipogenesis and its obesity-related metabolic alterations. 1107 
Nevertheless, they have also been useful for studying adipocyte renewal, expansion and donor 1108 
and depot-specific differences. 1109 
There are several benefits and limitations of different cell line models which must be 1110 
acknowledged; hence, this review assists with interpreting data and selecting a good cell line 1111 
model by creating a better understanding on the science of adipocytes and AT, as well as their 1112 
mechanism. The review also provides a detailed insight of available in vitro cell models which 1113 
enables the determination of the crucial factors and pathways that will assist in targeting new 1114 
pharmacological interventions against obesity and diabetes. Whilst 3D cultures and co‐cultures 1115 
of adipocytes with other cell types have been used as crucial tools to elucidate the multiple 1116 
metabolic connections between fat and other tissues.  1117 
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List of Abbreviation 1131 
PPARγ Peroxisome Proliferator-Activated Receptor-γ 
AT Adipose Tissue 
WAT  White Adipocytes Tissue 
BAT Brown Adipocytes Tissue 
UCP1 Uncoupling protein-1 
PPARα Peroxisome Proliferator-Activated Receptor-α 
mESCs Mouse Embryonic Stem Cells 
MEFs Mouse Embryonic Fibroblasts  
RA Retinoic acid 
T3 Triiodothyronine 
MSCs Mesenchymal Stem Cells 
DEX Dexamethasone 
IBMX 3-isobutyl-1-methylxanthine 
DMEM Dulbecco's modified Eagle's medium  
FBS Fetal bovine serum 
PGC-1α Peroxisome Proliferator-Activated Receptor-gamma Coactivator-1α  
PRDM16 PR domain containing 16 
C/EBPα CCAAT/enhancer-binding protein-α 
C/EBPβ CCAAT/enhancer-binding protein-β 
C/EBPδ CCAAT/enhancer-binding protein-δ  
aP2 Adipocyte Protein 2 
Pref-1 Preadipocyte factor 1 
LPL Lipoprotein lipase 
SREBP-1c Sterol regulatory element-binding protein-1c  
FABP4 Fatty Acid-Binding Protein 4 
FAS Fatty acid synthase  
HSL Hormone-sensitive lipase  
LPL Lipoprotein lipase 
CPT1 Carnitine palmitoyltransferase I 
SVF Stromal vascular fractions 
ACS Adipose stromal/stem cells  
IL-6 Interleukin 6  
IL-1β Interleukin 1β 
RUNX2 Runt-related transcription factor 2 
DGATs Diacylglycerol acyltransferases 
SCD1 Stearoyl-CoA desaturase 1  
ATGL Adipose triglyceride lipase  
AMPK AMP-activated protein kinase  
ACC Acetyl-CoA carboxylase  
Akt Protein Kinase B  
GLUT4 Glucose transporter type 4  
FOXO3a Forkhead box O3  
PLIN Perilipin 1 
TNFα Tumor necrosis factor-α  
NPY Neuropeptide Y  
NPYR Neuropeptide Y receptor  
EBs Embryoid bodies  
LIF Leukemia inhibitory factor  
MAPK Mitogen-activated protein kinase 
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